Accumulating evidence indicated that Th17-IL-17 axis mediates the progression from NASH to HCC 21, 22, while blockage of Th17-IL-17 axis can inhibit this progression 23. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.